Back to Results
First PageMeta Content
Clinical research / Pharmacology / Microbiology / Pharmaceutical industry / Design of experiments / Office of the Gene Technology Regulator / Cholera / Clinical trial / Genetically modified organism / Medicine / Health / Biology


10 April[removed]Issue of licence DIR 126 to PaxVax Australia Pty Ltd for a clinical trial of a genetically modified vaccine against cholera On 24 January 2014, the Gene Technology Regulator invited submissions on the cons
Add to Reading List

Document Date: 2015-03-06 01:50:22


Open Document

File Size: 46,39 KB

Share Result on Facebook

Company

PaxVax Australia Pty Ltd / /

IndustryTerm

therapeutic product / /

MedicalCondition

cholera / /

Organization

office of the Gene Technology Regulator MDP / Australian Government / Gene Technology Technical Advisory Committee / office of the Gene Technology Regulator / Therapeutic Goods Administration / /

/

Position

Minister / Governor / /

ProvinceOrState

Western Australia / Queensland / South Australia / Victoria / /

Region

South Australia / Western Australia / /

URL

http /

SocialTag